Carcinogenic Metabolites Formed from Antiestrogens
Carcinogenic Metabolites Formed from Antiestrogens
批准号:
7622809
负责人:
Judy L Bolton
金额:
$21.59万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-01-08 至 2009-06-30
关键词:
Adverse effectsAffinity ChromatographyAlkylationAlzheimer&aposs DiseaseAvidinBiologicalBiological AssayBiotinBreastBreast Cancer PreventionCarcinogensCardiovascular DiseasesCell LineCell RespirationCellsCharacteristicsChemistryChemopreventive AgentClassClinicClinicalClinical TrialsDNADNA AdductsDNA DamageDevelopmentElectrophoresisEndometrialEndometrial CarcinomaEndometriumEnzymesEquus caballusEstrogen AntagonistsEstrogen Receptor ModulatorsEstrogensGenerationsHandHealthHeartHeat shock proteinsHistonesHormonalHormonesHot flushesImplantIncidenceInvasiveLaboratoriesLasofoxifeneLesionLigationLinkLiteratureLiverMalignant NeoplasmsMammary glandMenopausal hot flushesMethodologyModificationNaphtholsNational Surgical Adjuvant Breast and Bowel ProjectNuclear ProteinNuclear ProteinsNude MiceO-(biotinylcarbazoylmethyl)hydroxylamineOsteoporosisOxidation-ReductionParentsPharmaceutical PreparationsPlacebosPostmenopauseProtein Disulfide IsomeraseProteinsQuinonesRaloxifeneRateRattusReactionRelative (related person)ReportingRiskSelective Estrogen Receptor ModulatorsSiteStagingStructureStudy modelsSubcellular FractionsSulfurTamoxifenTestingTimeTissuesTriphenylethyleneWomanWomen&aposs HealthWorkadductanalogbasebehavior influencebenzoquinonebenzothiophenebonecarcinogenesiscarcinogenicitycell transformationcellular targetingdesigndrug developmentmalignant breast neoplasmmetaplastic cell transformationnervous system disordernoveloxidationpreventquinone methideresearch studystress proteintumortumorigenic
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Development of the "perfect" selective estrogen receptor modulator (SERM) is of paramount importance in
postmenopausal women's health. The beneficial and undesirable side effects of SERMs are directly
analogous to estrogens, which are known carcinogens through a mechanism involving oxidative metabolism to
redox active/electrophilic quinoids. We hypothesize that the adverse effects of SERMs are also related to
their oxidative metabolism to quinoids. Whether these quinoids are detrimental are unknown at this time and it
is the focus of this proposal to determine the effect of structure on these mechanisms in an effort to provide
crucial information leading to the development of the "perfect" SERM. The specific aims are: 1. Effect of
structure on the formation and reactivity of SERM quinoids. We have shown that classical quinone methides,
di-quinone methides, and o-quinones are produced from triphenylethylene, benzothiophene, and
miscellaneous SERMs. We plan to examine the relative abilities of new classes of SERMs such as
bazodoxifene and lasofoxifene as well as the Lilly naphthol analogs to be oxidized to quinoids. The rate of
formation, type of quinoid, as well as their reactivity will be studied in subcellular fractions and Ishikawa
endometrial cells. 2. What are the protein targets of SERM quinoids? In the current proposal, we plan to use
the COATag methodology and "click chemistry" or modified Staudinger ligation approaches to examine protein
covalent modification in rat mammary subcellular fractions and Ishikawa cells. The targeted proteins will be
isolated using avidin affinity chromatography, separated by 2D electrophoresis, digested, and analyzed by
MALDI-TOF and LC-MS-MS. We predict that the reactivity of SERM quinoids will have a strong influence on
which proteins are modified as well as sites of protein alkylation within the target proteins. 3. Do SERM
quinoids modify DNA and induce cellular transformation? This aim will focus on how the type and reactivity of
SERM quinoid formed will dictate the extent of DNA damage. Initial model studies with deoxynucleosides and
DNA will allow characterization of stable DNA adducts, analysis of depurinating adducts, as well as
determination of DNA oxidation. We will then analyze SERM-induced DNA damage in Ishikawa cell lines.
Apurinic sites (AP) will be directly quantified using the aldehyde reactive probe assay and the transversions
and transitions resulting from these mutagenic lesions will be detected by mismatch-capture methodology.
Finally, transformation studies will be performed in MCF-10A cells and the transformed clones will be
implanted into athymic nude mice to investigate their ability to induce tumor formation. These studies will
elucidate the relative importance of quinoid formation and cellular targets for each SERM, thereby enabling
correlations of reactivity with structure from which general principles influencing the behavior of SERM quinoids
in cells will emerge.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of electrophilic/redox active quinoids in estrogen carcinogenesis
-
批准号:7786288
-
项目类别:
-
资助金额:$29.14万
-
财政年份:2007
-
负责人:Judy L Bolton
-
依托单位:
Role of electrophilic/redox active quinoids in estrogen carcinogenesis
-
批准号:8037167
-
项目类别:
-
资助金额:$29.14万
-
财政年份:2007
-
负责人:Judy L Bolton
-
依托单位:
Role of electrophilic/redox active quinoids in estrogen carcinogenesis
-
批准号:7491755
-
项目类别:
-
资助金额:$29.14万
-
财政年份:2007
-
负责人:Judy L Bolton
-
依托单位:
Role of electrophilic/redox active quinoids in estrogen carcinogenesis
-
批准号:8072619
-
项目类别:
-
资助金额:$28.26万
-
财政年份:2007
-
负责人:Judy L Bolton
-
依托单位:
Role of electrophilic/redox active quinoids in estrogen carcinogenesis
-
批准号:7303189
-
项目类别:
-
资助金额:$29.14万
-
财政年份:2007
-
负责人:Judy L Bolton
-
依托单位:
MECHANISMS OF ACTION IN MENOPAUSE
-
批准号:6954972
-
项目类别:
-
资助金额:$20.45万
-
财政年份:2005
-
负责人:Judy L Bolton
-
依托单位:
Symposium on Mechanisms of estrogen carcinogenesis
-
批准号:6415051
-
项目类别:
-
资助金额:$1.29万
-
财政年份:2001
-
负责人:Judy L Bolton
-
依托单位:
Estrogenic Agents--In Vitro and In Vivo Evaluation
-
批准号:6357004
-
项目类别:
-
资助金额:$24.84万
-
财政年份:2000
-
负责人:Judy L Bolton
-
依托单位:
Carcinogenic Metabolites formed from Antiestrogens
-
批准号:6582106
-
项目类别:
-
资助金额:$27.11万
-
财政年份:1999
-
负责人:Judy L Bolton
-
依托单位:
Carcinogenic Metabolites formed from Antiestrogens
-
批准号:7175312
-
项目类别:
-
资助金额:$21.59万
-
财政年份:1999
-
负责人:Judy L Bolton
-
依托单位:
Carcinogenic Metabolites Formed from Antiestrogen
-
批准号:7588719
-
项目类别:
-
资助金额:$22.99万
-
财政年份:1999
-
负责人:Judy L Bolton
-
依托单位:
CARCINOGENIC METABOLITES FORMED FROM ANTIESTROGENS
-
批准号:6489174
-
项目类别:
-
资助金额:$19.75万
-
财政年份:1999
-
负责人:Judy L Bolton
-
依托单位:
Carcinogenic Metabolites formed from Antiestrogens
-
批准号:6841939
-
项目类别:
-
资助金额:$22.81万
-
财政年份:1999
-
负责人:Judy L Bolton
-
依托单位:
Carcinogenic Metabolites formed from Antiestrogens
-
批准号:6989092
-
项目类别:
-
资助金额:$22.26万
-
财政年份:1999
-
负责人:Judy L Bolton
-
依托单位:
Carcinogenic Metabolites Formed from Antiestrogen
-
批准号:8281364
-
项目类别:
-
资助金额:$22.3万
-
财政年份:1999
-
负责人:Judy L Bolton
-
依托单位:
Carcinogenic Metabolites Formed from Antiestrogen
-
批准号:8074410
-
项目类别:
-
资助金额:$22.3万
-
财政年份:1999
-
负责人:Judy L Bolton
-
依托单位:
CARCINOGENIC METABOLITES FORMED FROM ANTIESTROGENS
-
批准号:2736684
-
项目类别:
-
资助金额:$19.93万
-
财政年份:1999
-
负责人:Judy L Bolton
-
依托单位:
CARCINOGENIC METABOLITES FORMED FROM ANTIESTROGENS
-
批准号:6137703
-
项目类别:
-
资助金额:$18.62万
-
财政年份:1999
-
负责人:Judy L Bolton
-
依托单位:
Estrogenic Agents--In Vitro and In Vivo Evaluation
-
批准号:6210610
-
项目类别:
-
资助金额:$24.84万
-
财政年份:1999
-
负责人:Judy L Bolton
-
依托单位:
CARCINOGENIC METABOLITES FORMED FROM ANTIESTROGENS
-
批准号:6342124
-
项目类别:
-
资助金额:$19.17万
-
财政年份:1999
-
负责人:Judy L Bolton
-
依托单位:
海外基金